ABSTRACT. Male weaning rats were pair-fed a low-zinc diet or a control diet. After 10 d, the animals fed the lowzinc diet showed physiologic signs of deficiency; however, they showed no clinical symptoms. Their estimated whole body zinc was 25 pmol versus 39 pmol for the controls. The 65Zn absorption increased 2-fold and the tissue distribution altered: muscle and erythrocytes contained more, small intestine and liver less activity at 0.5 h postdose. In vitro, the erythrocyte "Zn uptake rate increased also. The "Zn uptake experiments required small quantities of erythrocytes. The difference observed between the deficient and control cells was significant and showed little overlap. The increase of the 6sZn uptake from a medium was not affected when the animals underwent endotoxin exposure 24 h before, as was reported to occur in whole blood 65Zn uptake. Therefore, we suggest the in vitro erythrocyte 65Zn uptake, performed in a standardized, near physiologic medium, to detect early, subclinical zinc deficiency. (Pediatr Res 29: 391-395,1991)
The occurrence of zinc deficiency is not well defined. Its clinical signs are often milder than those that the patients with acrodermatitis enteropathica suffer from. This inborn error of zinc absorption causes severe chronic deficiency. Yet, the extent of its symptoms varies but it is not understood why. To affirm the diagnosis, elaborate tests have been designed to demonstrate the low absorption using radioactive 65Zn (1) . A reliable parameter to estimate the extent of the deficiency is not available. Besides the chronic deficiency in acrodermatitis enteropathica, other zinc deficiencies are believed to occur in otherwise wellnourished children. In a group of children suffering from recurrent upper respiratory tract infection, evidence of subacute deficiency was demonstrated. In another group with acute diarrhea, acute zinc deficiency was observed. Growth was hampered in both groups of children. Walravens and coworkers (2, 3) have proven the existence of a growth-limiting syndrome caused by subclinical zinc deficiency; in supplemented children, growth was enhanced. In the absence of a reliable test, the response to zinc treatment has been used to detect deficiency in children.
In laboratory animals, various degrees of dietary deficiency can be induced. They serve as a model to study the identification of a suitable parameter that reflects the degree of deficiency.
From earlier results, we advocate the use of plasma sp act (65Zn per total Zn) after administration of 65Zn to detect deficiency (4). The use of 65Zn in vivo is generally limited. By a variant experimental design, we induced subclinical deficiency in animals (5) . In the present study, we monitored the zinc status and its regulation in subclinically deficient weaning rats. The zinc status was characterized not only by tissue zinc contents, tissue 65Zn distribution, and sp act, but also by in vitro erythrocytic 65Zn uptake experiments (6) . Regulation of the zinc status was measured by whole body 65Zn absorption, excretion, and turnover. On the basis of the results, we evaluated the suitability of the parameters to detect subclinical deficiency.
MATERIALS AND METHODS
Animals and diets. Male weaning Wistar rats (special pathogen-free; strain Cpb/WU; random bred; CPB-Harlan, Zeist, the Netherlands), weighing approximately 50 g, were randomly assigned to deficient (30 pmol Zn/kg) or control (150 pmol Zn/ kg) semisynthetic Interfaculty Reactor Institute OvalbuminBased diets (Hope Farms, Woerden, the Netherlands) (for diet com~osition, see 6). Pair-feeding between control (n = 60) and expenmental (n = 60) animals was maintained during the entire study. Food was removed the night before 65Zn was offered and also before the animals were killed. The rats were individually housed in Macrolon cages with stainless steel lids (Techniplast 170011; Gazzada, Buguggiate, Italy) and the rats had free access to double-distilled water with 0.1-0.2 pmol Zn/L (by analysis). The cages were placed in an air-conditioned room (20 k 1°C) with a relative humidity of 55%. A fixed day-night rhythm was applied (light from 6 to 18 h). Body weight was recorded daily before feeding.
Zinc status. After being fed the experimental diets for 10 d, 12 animals of each group were killed under COz anesthesia. Blood was collected and dissection of the carcass was performed with stainless steel instruments. The reagents used were of analytical grade and all utensils were rinsed with 5% HCl. Samples of the left hepatic lobe, the pancreas, the duodenum and adjacent jejunum over a total length of 5 cm, the right tibia, the flexor digitorum muscle, and fur and hair of the abdominal region were prepared. The lumen of the proximal small intestine sample was first rinsed with saline. The tissues were weighed and freeze-dried for 48 h. Then they were dissolved with 65% nitric acid for I h at 70°C (Suprapur; E. Merck, Darmstadt, Germany) and subsequently with 30% hydrogen peroxide (Aristar; BDH Chemicals, Poole, UK). The plasma was separated by centrifugation at 1300 x g at 4°C for 30 min, the buffy coat was removed, and the erythrocytes were washed with saline at 4°C (double-distilled water and Baker Analysed NaCl; Baker, Deventer, the Netherlands). VAN wou WE ET AL.
Zinc concentration in urine, plasma, and ashed tissues was determined by atomic absorption spectrometry (no. 2380; Perkin Elmer, Norwalk, CT) in duplicate. The amount of zinc in whole tissues was calculated using the fractional weight of the tissues as derived from the literature (7) and the dry weightlwet weight ratios as determined in earlier experiments ( Table 1) . As shown in Table 1 ,83.5% of the animal weight was accounted for. Whole body zinc was approximated by totaling the zinc inventories of these tissues and multiplying the resulting sum by the factor 1001 83.5. The urine of six animals of each group was collected over 10 d. In addition to zinc, creatinine and total nitrogen were determined in the pooled urine by routine clinical chemical methods.
Regulation of zinc status. "Zn studies were started in another 12 animals of each group on experimental d 6. First, the apparent retention, the biologic half-life, and the absorption were determined. Half (six rats) of each group were given "Zn (0.5 pmol Zn/70 g body wt) by orogastric tube. The other half (six rats) of each group were injected intraperitoneally with a smaller dose (0.05 pmol "Zn/70 g body wt). In all 12 animals, whole-body counting was performed on d 0 (2 h after dose, this activity was set equal to 100% dose) and then daily from d 13 to 2 1 with a specially designed whole-body counter for rats (8) consisting of a container filled with a scintillation liquid (pseudo-cumene) and fitted with a centrally positioned "well" (0.06 x 0.20 m). Measurements were calibrated daily with a 65Zn standard and corrections for decay and background were made. $ p < 0.001 (analysis of variance).
5 After an overnight fast.
11 17 < 0.0 I (analysis of variance).
The apparent retention, Ro, was calculated from the linear fit versus time of the countings between d 13 and 21 of the animals injected with "Zn expressed as natural logarithm of the dose in
where R, is the activity in the animal in % dose at time t, a is a constant, t is the time in days, and Ro is the activity extrapolated to t = 0, the apparent retention in % dose. The biologic half-life, T,, was calculated from a:
The apparent absorption, Ao, was calculated analogously in the animals that received the 65Zn by intubation:
The ratio of apparent absorption and apparent retention is the true absorption, A, being:
In vivo "Zn distribution. In the third experiment, another 12 animals of each group were killed 10 d after starting the Interfaculty Reactor Institute Ovalbumin-Based diets and 30 min after an oral dose (0.5 pmol Znj70 g body wt) of "Zn (27 GBq/mol; The Radiochemical Center, Amersham, UK). 65Zn activities in the tissues given in Table 1 (except fur) and the content rinsed from the proximal small intestine were measured with a gammacounter at a window setting of 960-1240 keV. The duration of countings was adjusted to assure an error due to counting statistics of < I % . The total 6SZn activity in the tissues was calculated using the fractional weight distribution (Table I) . Dose distribution and absorbed "Zn activity distribution were calculated separately and averaged for the two groups of 12 animals each.
In vitro erythrocyte 65Zn uptake. Of the remaining animals, 18
of each group were killed on d 10. Samples of 0.3 mL of pooled and washed erythrocytes were incubated in vitro with either 0.3 mL "Zn tracer in pooled plasma from the deficient (total zinc 11 pmol/L) or control animals (22 pmol/L), respectively. The incubation was carried out in a shaking water bath at 37°C for 1 h and was stopped by cooling in ice water and centrifugation at 4°C. The erythrocytes were washed three times with saline, after which no activity was left in the last supernatant. Erythrocytes of other animals were incubated in 7. Finally, to test the possible effect of endotoxin on erythrocyte 65Zn uptake, cells of the remaining six rats of each diet group were collected. These animals were killed 24 h after intraperitoneal injection of Escherichia coli endotoxin (lipopolysaccharide B: 2 mg/kg body wt; dissolved in 0.5 mL saline; 055:B5; Sigma Chemical Co.).
All statistical comparisons were performed by analysis of variance and regression analysis. SD were calculated by the usual error propagation rules. Sensitivity and specificity were calculated by the overlap index according to Hartz (9). jj Taking into account that 83.5% of the animal was sampled and that for the whole body a correction factor of 100/83.5 was applied. $Taking into account that 83.5% of the animal was sampled and that for the whole body a correction factor of 100/83.5 was applied.
RESULTS AND DISCUSSION
Characterization of deficiency. The animals fed the deficient diet ate less than the controls. They determined the food intake of the controls at pair-feeding. In 9 d, 60 g food per animal were consumed. At the end of the experiment, differences in body weight between the two groups were significant (Table 2) . Normal growth of animals of this size fed commercial food (different composition and 600 pmol Zn per kg) ad libitum is 2.6 + 1.0 g/ d (CPB-Harlan). Thus, pair-feeding limited the food intake of the controls and resulted in reduction in growth by approximately 25%. Urine creatinine remained unaltered; total nitrogen excretion increased gradually in the deficient group. Early deficiency causes growth retardation with low utilization of dietary protein.
In deficiency, the zinc status and its regulation altered. The zinc concentrations decreased in bone, pancreas, and plasma, and the concentration in fur increased (Table 3) . Bone and pancreas levels indicate the dietary deficiency best, showing higher significance and no overlap. The whole-body zinc was 25 pmol, compared with 39 pmol in the controls. This is mainly due to a decrease of bone zinc. In the previous study, which lasted longer (4), the bone zinc decreased further to 7.4 pmol in the total skeleton on d 21, compared with 19.6 pmol in the controls.
The results of the whole-body counting as a function of time after the oral 65Zn show increased absorption and retention in deficient animals (Table 4) . When measuring the "Zn activities in tissues 30 min after a similar oral dose, the "Zn activity was higher in the tissues sampled, except in liver and small intestine (Table 5 ). Corresponding higher tissue sp act were recorded, except in the small intestine and liver (Table 6 ). Inasmuch as no activity could be rinsed from the intestinal lumen 30 min after ingestion, it is assumed that the sum of activity of all tissues reflects the absorption, if corrected for sampling only 83.5% of the animal weight. The absorption at 30 min was 92% (Table 5) . This average value exceeds the true absorption calculated from whole-body countings although due to the error margins involved the difference is not significant. Between the tissues, there are differences implying that homogenous distribution has not been reached during the 30 min postdose. Increased sp act is the result of increased 65Zn uptake, a compensation mechanism of the deficiency. Liver and small intestine do not seem to compensate, bone and muscle compensate only a little, and plasma, pancreas, and erythrocytes compensate for the deficiency immediately.
Each animal ate 60 g food in 9 d. The animals were metabolically in steady state. The oral hsZn, 0.5 pmol/70 g body wt, is in the range of the daily amount offered in the diet (-7 + 2 g), viz. 0.2 + 0.1 pmol Zn/50 body wt and I. 1 + 0.3 pmo1/65 g in the two groups, respectively. In summary, the animals fed the low-zinc diet showed physiologic signs of deficiency besides the growth retardation and low utilization of dietary protein. However, they showed no other clinical signs of deficiency such as skin defects (5). The absorption of h5Zn was doubled and its tissue distribution altered: increased sp act is shown in plasma, pancreas and erythrocytes.
In vitro experiments. Fresh erythrocytes were incubated in vitro with 65Zn-labeled plasma. The "Zn uptake rate in deficient cells was 1.5 to 1.7 times higher than in the control cells. A similar difference in "Zn uptake rate, viz. a factor of 2.1, was demonstrated when incubating in a standardized, near physiologic medium, instead of plasma (Table 7 ). In the animals, the in vivo uptake increased by a factor of approximately 8 during low dietary Zn intake (Table 5 ). This factor is partly due to lower total plasma zinc (reduction 0.01 1/0.022 = 0.5) and higher plasma "Zn activity (increase 8,913.8 = 2.3) leading to an increased sp act (increase 2.310.5 = 4.7). In case of equal in vivo uptake rates, the uptake rate of "Zn would have been 4.7 times higher. However, as mentioned, a factor of 8 was found, indicating that the "Zn uptake rate of deficient erythrocytes increases by a factor of 1.7. Thus, the in vivo and in vitro results for erythrocyte "Zn uptake agree well. However, this agreement may be artificial, because the in vivo uptake might be influenced by factors that are absent in vitro, e.g. the differences in the rate 394 VAN $ Total tissue "Zn activities 0.5 h after an ingested dose, mean value (n = 12) in % absorption, by separate calculations.
5 p < 0.0 I (analysis of variance). 11 p < 0.00 1 (analysis of variance).
1 Taking into account that 83.5% of the animal was sampled and that for the whole body a correction factor of 100/83.5 was applied.
** Set to 100%. The results of these experiments show that the difference in erythrocyte "Zn uptake is not due to differences in ghost bound activity: the 65Zn activity in the ghosts is equal for both groups. Finally, the increase in erythrocyte 65Zn uptake during deficiency is unaffected by endotoxin, which alters the whole body 65Zn absorption, excretion, and turnover (4) . Diagnostic implications. In our previous study involving prolonged, clinical zinc deficiency, significant differences in the specific zinc activity in plasma have been observed after 21 d. The present study demonstrates that significant differences in plasma sp act also occur in the situation of an early subclinical deficiency. Thus, differences in specific zinc activity in plasma shortly after administration of radioactive zinc may form the basis of a clinical test. However, the clinical applicability of radioactive zinc for diagnostic purposes in vivo is limited, and restricted to the critically ill. A way out is the use of isotopically enriched stable zinc isotopes. A serious drawback of this latter method is its elaborate and time-consuming character, entailing high costs and highly specialized laboratories. The present study demonstrates that early, subclinical deficiency causes an increased erythrocyte 65Zn uptake. Because this effect occurs also in vitro, it may be used as a basis for a clinical test to detect subclinical deficiency. Such an in vitro test has the advantage that no radioactivity is administered to patients. Furthermore, the test is simple to perform, requiring only a small amount of erythrocytes, which usually go to waste in routine clinical laboratories. Therefore, we advocate the erythrocyte 65Zn uptake as a test to detect early, subclinical zinc deficiency.
In our animal model, increased in vitro erythrocyte 65Zn uptake appears to be sensitive and specific. Being an in vitro test, only erythrocyte properties are tested. Neither plasma nor other tissues may influence the results in an uncontrolled manner as is the case for in vitro whole blood "Zn uptake. Endotoxin does not affect the uptake results if performed in nearly physiologic medium, whereas it does disturb the whole blood (j5Zn uptake (1 I, 12) .
